Active Comparator #1
PreclinicalSmall molecule
EisaiActive Comparator #1 is one of 45 small molecule programs targeting Low back pain. It is currently in Preclinical.
1
Indications
3
Total Trials
2
Active Trials
44
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
54 competitors in Low Back Pain
#DrugCompanyPhaseTrials
1Cymbalta
Jazz PharmaceuticalsApproved
Aleve
Jazz PharmaceuticalsApproved
Voltaren
NovartisApproved
Advil
KKenvue Brands
Approved
Lioresal
NovartisApproved
Toradol
RocheApproved
Celebrex
PPhiladelphia Eye Associates
Approved
Oxycontin
PProtega
Approved
Bayer Aspirin
BayerApproved
MS Contin
HHikma Pharmaceuticals LLC
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Active Comparator #1. EMBL-EBI & Wellcome Sanger Institute.
- [4]